Sleemon Healthy Sleep Technology Co., Ltd. (SHA:603008)
China flag China · Delayed Price · Currency is CNY
8.96
-0.47 (-4.98%)
May 21, 2026, 3:00 PM CST

SHA:603008 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3007,5436,3526,59011,06114,887
Market Cap Growth
-46.02%18.75%-3.61%-40.42%-25.70%98.89%
Enterprise Value
4,2407,8846,9507,39711,96215,497
Last Close Price
8.9620.4816.0115.8426.5035.94
PE Ratio
24.4931.2419.7015.3746.5626.64
Forward PE
6.3515.6311.9010.9015.0922.77
PS Ratio
0.380.860.730.761.411.92
PB Ratio
0.922.091.621.672.984.40
P/TBV Ratio
1.102.471.962.073.725.48
P/FCF Ratio
11.1130.1814.949.69-70.37
P/OCF Ratio
3.828.978.075.2613.1521.16
PEG Ratio
-0.680.680.680.680.68
EV/Sales Ratio
0.480.890.800.851.531.99
EV/EBITDA Ratio
7.5713.5411.029.7024.6918.79
EV/EBIT Ratio
12.5319.0918.6914.4635.7722.48
EV/FCF Ratio
14.2831.5516.3510.87-73.26
Debt / Equity Ratio
0.720.670.560.460.660.56
Debt / EBITDA Ratio
4.573.673.512.404.222.16
Debt / FCF Ratio
8.629.645.212.69-8.88
Net Debt / Equity Ratio
0.250.04-0.05-0.070.070.04
Net Debt / EBITDA Ratio
1.820.24-0.32-0.360.500.18
Net Debt / FCF Ratio
2.980.57-0.47-0.40-18.100.69
Asset Turnover
1.031.000.980.970.900.98
Inventory Turnover
6.386.406.015.114.625.57
Quick Ratio
0.720.810.820.780.790.78
Current Ratio
1.031.121.091.081.101.10
Return on Equity (ROE)
3.55%6.31%8.31%11.70%7.66%18.46%
Return on Assets (ROA)
2.49%2.94%2.61%3.56%2.41%5.43%
Return on Invested Capital (ROIC)
5.52%8.24%9.28%10.82%7.54%17.62%
Return on Capital Employed (ROCE)
8.20%9.20%8.40%11.30%7.60%17.10%
Earnings Yield
4.07%3.20%5.08%6.51%2.15%3.75%
FCF Yield
9.00%3.31%6.69%10.32%-0.12%1.42%
Dividend Yield
8.93%2.73%3.25%3.16%0.30%0.78%
Payout Ratio
271.06%150.61%80.09%21.41%79.50%29.42%
Buyback Yield / Dilution
2.08%2.07%1.84%-0.84%0.57%1.64%
Total Shareholder Return
11.01%4.80%5.09%2.31%0.88%2.42%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.